Synopsys SNPS shares plunged 20.8% over the past year, underperforming the Zacks Computer - Software industry, Zacks Computer and Technology sector and the S&P 500 index’s growth of 3.5%, 19.2% and 18 ...

Synopsys’ (SNPS) CEO Sassine Ghazi, recently sold the company’s shares worth $5.37 million. SNPS is a software company that ...

We recently compiled a list of the 11 Oversold Blue Chip Stocks to Buy According to Hedge Funds. In this article, we are ...

State Medicaid agencies can improve D-SNP financial transparency and reward those D-SNPs that provide the best value to ...

Synopsys and Cadence, beyond EDA software, provide Intellectual Property and collect licensing and royalty fees. Click to ...

Synopsys (NasdaqGS:SNPS) announced the launch of its Virtualizer Native Execution platform for Arm-based hardware, targeting key sectors like automotive and IoT, likely influencing its stock price ...

Dual eligibles — that is, people eligible for both Medicare and Medicaid — have a wealth of Medicare options. These ...

Nursing home patients’ enrollment in I-SNPs has been tied to better performance on six of eight major indicators.

Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) reached a new 52-week low during mid-day trading on Monday following insider selling activity. The company traded as low as $427.30 and last traded at ...

In this article, we are going to take a look at where Synopsys, Inc. (NASDAQ:SNPS) stands against other tech stocks with high upside potential. As per Forrester Research, Inc., despite persistent ...

Unsure how to manage LTC residents, particularly high-needs and frail older adults, health care payers such as managed care ...

Diets high in whole grains, fruits, vegetables, and dietary fiber have been linked with lowering the risk of developing colorectal cancer. But how they work is not fully known.  Scientists think ...